This chapter examines the role of biomarkers in the assessment of inflammatory bowel disease (IBD) during pregnancy. The pregnant state is unique as it requires consideration of the wellbeing of both mother and foetus. It is now established through multiple studies that active IBD can lead to ad...
4. Joana Torres, et al. European Crohn, s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. Journal of Crohn, s and Colitis. 2023 Jan;17(1):1-27.
我将带着满满的收获,继续努力学习,和更多的人一起更好的服务患者,让他们拥有更好的生活质量。 参考文献:Torres J, Chaparro M, Julsgaard M, et al. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and...
Pregnancy and IBD: Preliminary Results from the Helmsley Global Consensus Grade Conference Date: 5/19/24 @ 10:00 am Location: Ballroom B – Walter E. Washington Convention Center Description: There is fear surrounding the impact of IBD and its therapies on pregnancy and infant outcomes, as well...
Torres J, Chaparro M, Julsgaard M, et al. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation [published online ahead of print, 2022 Aug 25]. J Crohns Colitis. 2022;jjac115. doi:10.1093/ecco-jcc/jjac115 ...
The majority of medications for IBD are safe in pregnancy and breastfeeding. While the weight of retrospective data is encouraging, the advent of newer therapies and biologics make decision-making about childbearing more difficult. There is currently a large insurance database study under way to ass...
Purpose of reviewThis review summarizes the most current clinical research and latest clinical guidelines in managing inflammatory bowel disease (IBD) before, during, and after pregnancy.Recent findingsRecent guidelines emphasize the safety of thiopurines and biologics during pregnancy and nursing. Patients...
策划:颜泽林,梦君 责编:梦君 参考文献: [1]Torres J, Chaparro M, Julsgaard M, et al. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. J Crohns Colitis. 2023. 17(1): 1-27.
Pregnancy Considerations Animal studies have not shown a risk of fetal harm associated with most biologics, but there are no good-quality studies available in humans. Generally speaking, their benefits in IBD treatment are expected to outweigh any possible risks.4 ...
Exclusion criteria for both cases and controls included: lack of information regarding medical or nutritional status evaluation in either consecutive clinical visit; patients with a stoma, pregnancy or malnutrition diagnosed during the index visit. Controls were also excluded if they had developed ...